Consolidated Statements of Earnings (Losses) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net revenues	$ 26,153	$ 25,110	$ 25,364
Cost of sales	7,818	7,085	7,373
Excise taxes on products	5,312	5,314	5,737
Gross profit	13,023	12,711	12,254
Marketing, administration and research costs	2,154	2,226	2,756
Asset impairment and exit costs	(4)	159	383
Operating income	10,873	10,326	9,115
Interest and other debt expense, net	1,209	1,280	665
Net periodic benefit income, excluding service cost	(77)	(37)	(34)
(Income) losses from equity investments	111	(1,725)	(890)
Impairment of JUUL equity securities	2,600	8,600	0
Loss on Cronos-related financial instruments	140	1,442	0
Loss on ABI/SABMiller business combination	0	0	33
Earnings before income taxes	6,890	766	9,341
Provision for income taxes	2,436	2,064	2,374
Net earnings (losses)	4,454	(1,298)	6,967
Net (earnings) losses attributable to noncontrolling interests	13	5	(4)
Net earnings (losses) attributable to Altria	$ 4,467	$ (1,293)	$ 6,963
Per share data:
Basic earnings (losses) per share attributable to Altria (in usd per share)	$ 2.40	$ (0.70)	$ 3.69
Diluted earnings (losses) per share attributable to Altria (in usd per share)	$ 2.40	$ (0.70)	$ 3.68